77 related articles for article (PubMed ID: 19345324)
1. Lessons learned from the study of JunB: new insights for normal and leukemia stem cell biology.
Guzman ML; Jordan CT
Cancer Cell; 2009 Apr; 15(4):252-4. PubMed ID: 19345324
[TBL] [Abstract][Full Text] [Related]
2. PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cells.
Somervaille TC; Cleary ML
Cancer Cell; 2006 Dec; 10(6):456-7. PubMed ID: 17157786
[TBL] [Abstract][Full Text] [Related]
3. Cancer biology: a game of subversion.
Passegué E
Nature; 2006 Aug; 442(7104):754-5. PubMed ID: 16915276
[No Abstract] [Full Text] [Related]
4. Which are the leukaemic cells?
Lajtha LG
Blood Cells; 1981; 7(1):45-62. PubMed ID: 7187748
[TBL] [Abstract][Full Text] [Related]
5. Differentiation versus maturation of neoplastic hematopoietic cells: an important distinction.
Lichtman MA
Blood Cells Mol Dis; 2001; 27(3):649-52. PubMed ID: 11482879
[No Abstract] [Full Text] [Related]
6. Cancer stem cells refined.
Scadden DT
Nat Immunol; 2004 Jul; 5(7):701-3. PubMed ID: 15224098
[No Abstract] [Full Text] [Related]
7. Jun: stealth, stability, and transformation.
Vogt PK; Bader AG
Mol Cell; 2005 Aug; 19(4):432-3. PubMed ID: 16109367
[TBL] [Abstract][Full Text] [Related]
8. Transformation from committed progenitor to leukemia stem cells.
Krivtsov AV; Feng Z; Armstrong SA
Ann N Y Acad Sci; 2009 Sep; 1176():144-9. PubMed ID: 19796242
[TBL] [Abstract][Full Text] [Related]
9. [Stem cells and cancer: the last frontier?].
Larsen CJ
Bull Cancer; 2006 Nov; 93(11):1083-4. PubMed ID: 17145576
[No Abstract] [Full Text] [Related]
10. Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation.
Meixner A; Zenz R; Schonthaler HB; Kenner L; Scheuch H; Penninger JM; Wagner EF
Nat Cell Biol; 2008 Aug; 10(8):1003-11. PubMed ID: 18641637
[TBL] [Abstract][Full Text] [Related]
11. Leukaemia: niche retreats for stem cells.
Williams DA; Cancelas JA
Nature; 2006 Dec; 444(7121):827-8. PubMed ID: 17167463
[No Abstract] [Full Text] [Related]
12. Whiteness of Worcester.
Quesenberry PJ
Exp Hematol; 1998 Jun; 26(6):455-6. PubMed ID: 9620277
[No Abstract] [Full Text] [Related]
13. Stem cell exhaustion and leukemogenesis.
Jacob B; Osato M
J Cell Biochem; 2009 Jun; 107(3):393-9. PubMed ID: 19347871
[TBL] [Abstract][Full Text] [Related]
14. Upsides and downsides to polarity and asymmetric cell division in leukemia.
Hawkins ED; Russell SM
Oncogene; 2008 Nov; 27(55):7003-17. PubMed ID: 19029941
[TBL] [Abstract][Full Text] [Related]
15. The hunt for cancer-initiating cells: a history stemming from leukemia.
Buzzeo MP; Scott EW; Cogle CR
Leukemia; 2007 Aug; 21(8):1619-27. PubMed ID: 17541397
[TBL] [Abstract][Full Text] [Related]
16. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
17. [Self-renewal mechanisms of leukemic stem cells].
Iwama A
Rinsho Ketsueki; 2008 Jul; 49(7):445-54. PubMed ID: 18709974
[No Abstract] [Full Text] [Related]
18. Complexity of the human acute myeloid leukemia stem cell compartment: implications for therapy.
Dick JE
Biol Blood Marrow Transplant; 2005 Feb; 11(2 Suppl 2):9-11. PubMed ID: 15682167
[No Abstract] [Full Text] [Related]
19. Recurrence cancer stem cells--made by cell fusion?
Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
[TBL] [Abstract][Full Text] [Related]
20. [Targetting therapy of leakaemia stem cells].
Yang CZ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1372-4. PubMed ID: 17785053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
